<DOC>
	<DOCNO>NCT01248481</DOCNO>
	<brief_summary>To evaluate effectiveness Glucobay combine basal insulin daily-life treatment condition large sample Korean patient .</brief_summary>
	<brief_title>GlucoFriend-evaluation Effectiveness Glucobay When Combined With Basal Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Signed write informed consent Age ≥ 18 year Diagnosed type 2 diabetes least 6 month prior enrollment Patients treat stable dose basal insulin ( insulin glargine insulin detemir ) least 2 month HbA1C≥7.5 ≤10.0 % Exclusion criterion must read conjunction local product information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Acarbose/Glucobay®</keyword>
	<keyword>Basal insulin</keyword>
	<keyword>PPG ( Postprandial Glycaemia )</keyword>
</DOC>